A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Table of Contents BUSINESS & MARKET INFORMATION BUSINESS OVERVIEW We are a global leader in sequencing- and array-based solutions for genetic and genomic analysis. Our products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings. We were incorporated in California in April 1998 and reincorporated in Delaware in July 2000. Our principal executive offices are located at 5200 Illumina Way, San Diego, California 92122. Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.3B | 4.3B | 4.4B | 4.5B | 4.5B | 3.2B |
| Net Income | 850M | 850M | -1.2B | -1.2B | -4.4B | 656M |
| EPS | $5.45 | $5.45 | $-7.69 | $-7.34 | $-28.00 | $4.45 |
| Free Cash Flow | 931M | 931M | 709M | 283M | 337M | 891M |
| ROIC | 27.5% | 25.4% | -26.1% | -18.8% | -48.8% | 6.5% |
| Gross Margin | 66.1% | 66.1% | 65.4% | 60.9% | 69.7% | 68.0% |
| Debt/Equity | 0.37 | 0.37 | 0.73 | 0.26 | 0.08 | 0.07 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 807M | 807M | -833M | -1.1B | -4.2B | 580M |
| Operating Margin | 18.6% | 18.6% | -19.1% | -23.7% | -92.3% | 17.9% |
| ROE | 31.2% | 33.4% | -30.1% | -18.8% | -50.8% | 8.5% |
| Shares Outstanding | 156M | 156M | 159M | 158M | 157M | 147M |
ILLUMINA, INC. passes 4 of 9 quality checks, suggesting mixed fundamentals.
ILLUMINA, INC. trades at 23.9x trailing earnings, compared to its 15-year median P/E of 51.5x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 21.4x vs a median of 56.2x. The company's 5-year average gross margin is 66.0%. Total shareholder yield (buybacks) is 3.7%. At current prices, the estimated annualized return to fair value is -7.3%.
ILLUMINA, INC. (ILMN) has a current P/E ratio of 23.9, compared to its historical median P/E of 51.5. The stock is currently considered Cheap based on its historical valuation range.
ILLUMINA, INC. (ILMN) has a 5-year average return on invested capital (ROIC) of -12.4%. This is below average and may indicate limited pricing power.
ILLUMINA, INC. (ILMN) has a market capitalization of $20.3B. It is classified as a large-cap stock.
ILLUMINA, INC. (ILMN) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 3.65%.
Based on historical P/E analysis, ILLUMINA, INC. (ILMN) appears cheap. The current P/E of 23.9 is 54% below its historical median of 51.5. The estimated fair value CAGR (P/E method) is -5.4%.
ILLUMINA, INC. (ILMN) operates in the Laboratory Analytical Instruments industry, within the Technology sector.
ILLUMINA, INC. (ILMN) reported annual revenue of $4.3 billion in its most recent fiscal year, based on SEC EDGAR filings.
ILLUMINA, INC. (ILMN) has a net profit margin of 19.6%. This is a healthy margin.
ILLUMINA, INC. (ILMN) generated $931 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
ILLUMINA, INC. (ILMN) has a debt-to-equity ratio of 0.37. This indicates a conservatively financed balance sheet.
ILLUMINA, INC. (ILMN) reported earnings per share (EPS) of $5.45 in its most recent fiscal year.
ILLUMINA, INC. (ILMN) has a return on equity (ROE) of 33.4%. This indicates the company generates strong returns for shareholders.
ILLUMINA, INC. (ILMN) has a 5-year average gross margin of 66.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for ILLUMINA, INC. (ILMN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ILLUMINA, INC. (ILMN) has a book value per share of $17.46, based on its most recent annual SEC filing.